Raymond James lowered the firm’s price target on Kite Realty (KRG) to $28 from $31 and keeps a Strong Buy rating on the shares. The firm ...

Arizona State Retirement System grew its stake in Kite Realty Group Trust (NYSE:KRG – Free Report) by 0.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 63,750 shares ...

Jefferies Financial Group cut shares of Kite Realty Group Trust from a “buy” rating to a “hold” rating and reduced their price target for the stock from $31.00 to $27.00 in a report on ...

High-profile Republican priorities are advancing after the Iowa Legislature's first "funnel" deadline on Friday, while others ...

Independence Realty (IRT – Research Report) received a Buy rating and a $24.00 price target from Jefferies analyst Linda Tsai today. The ...

Gilead pounced to buy cell therapy company Kite in August last year for just under $12 billion, shortly before the biotech firm gained approval for its CAR-T cancer therapy Yescarta. Now Gilead is ...

The ongoing group exhibition "重" (Chong/Zhong) at Cai Jin Space in Beijing's 798 art district explores the absurdity of ...

Proving that local sailing fleets grow stronger by working together, Seattle's J/70 sailors and Ron Rosenberg celebrate the ...

Gruelling exertion, exhilaration, determination and a human tragedy all played a part in her 1979 Tour Of Life – and she ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

There’s nowhere on earth quite like the Outer Banks, a string of wild but well-loved barrier islands off the coast of North Carolina. Learn more about our 2025 Vacation of the Year.

The deal caps a turbulent three years for 2seventy bio. The company served as the oncology business of Bluebird Bio until Bluebird spun out 2seventy in 2021.